Table 2.

Management Characteristics and Outcomes of Adolescents and Adults With Sepsis, Northern Tanzania, September 2019–April 2020

 Total Cohort (n = 86)Sepsis Without Hypotension (n = 82)Sepsis With Hypotension (n = 4)
Management characteristics, h 0–6
Received antimicrobials by 2 h14 (16.3)14 (17.1)0
Received antimicrobials by 6 h29 (33.7)29 (35.4)0
 If received, time to antimicrobials by h 6, median (IQR), min129 (97–203)129 (97–203)n/a
Received any IV fluids by 3 h42 (51.2)38 (46.3)4 (100)
Received any IV fluids by 6 h49 (57.0)45 (54.9)4 (100)
 <1L IV fluids23 (46.9)20 (44.4)3 (75.0)
 1–2L IV fluids21 (42.9)20 (44.4)1 (25.0)
 >2L IV fluids5 (10.2)5 (11.1)0
 If received, total IV fluids by h 6, median (IQR), mL1000 (500–1500)1000 (500–1500)500 (350–750)
Blood cultures performed26 (30.2)25 (30.5)1 (25.0)
 If performed, obtained before antimicrobials given24 (92.3)23 (92.0)1 (100)
Other investigation for infectious source performeda65 (75.6)63 (76.8)2 (50.0)
Steroid administration3 (3.5)3 (3.7)0
Supplemental oxygen given17 (19.8)17 (20.7)0
Required emergent surgery1 (1.2)1 (1.2)0
Hospital course
Received ≥1 antimicrobial after admission48 (55.8)45 (54.9)3 (75.0)
Required vasopressors at any time2 (2.3)2 (2.4)0
Required supplemental oxygen at any time27 (31.4)26 (31.7)1 (25.0)
Intensive care unit at any time17 (19.8)16 (19.5)1 (25.0)
Outcomes
In-hospital death25 (29.1)24 (29.3)1 (25.0)
Length of stay, median (range), d4.5 (1–8)4.5 (1–8)5.5 (2.5–8)
Deaths by qSOFA and UVA scoresb
 qSOFA <29 (17.0) of 539 (17.0) of 530 of 0
 qSOFA ≥216 (48.5) of 3315 (51.7) of 291 (25.0) of 4
 UVA <24 (10.5) of 384 (10.8) of 370 (0) of 1
 UVA 2–49 (30.0) of 309 (31.0) of 290 (0) of 1
 UVA ≥512 (66.7) of 1811 (68.8) of 161 (50.0) of 2
 Total Cohort (n = 86)Sepsis Without Hypotension (n = 82)Sepsis With Hypotension (n = 4)
Management characteristics, h 0–6
Received antimicrobials by 2 h14 (16.3)14 (17.1)0
Received antimicrobials by 6 h29 (33.7)29 (35.4)0
 If received, time to antimicrobials by h 6, median (IQR), min129 (97–203)129 (97–203)n/a
Received any IV fluids by 3 h42 (51.2)38 (46.3)4 (100)
Received any IV fluids by 6 h49 (57.0)45 (54.9)4 (100)
 <1L IV fluids23 (46.9)20 (44.4)3 (75.0)
 1–2L IV fluids21 (42.9)20 (44.4)1 (25.0)
 >2L IV fluids5 (10.2)5 (11.1)0
 If received, total IV fluids by h 6, median (IQR), mL1000 (500–1500)1000 (500–1500)500 (350–750)
Blood cultures performed26 (30.2)25 (30.5)1 (25.0)
 If performed, obtained before antimicrobials given24 (92.3)23 (92.0)1 (100)
Other investigation for infectious source performeda65 (75.6)63 (76.8)2 (50.0)
Steroid administration3 (3.5)3 (3.7)0
Supplemental oxygen given17 (19.8)17 (20.7)0
Required emergent surgery1 (1.2)1 (1.2)0
Hospital course
Received ≥1 antimicrobial after admission48 (55.8)45 (54.9)3 (75.0)
Required vasopressors at any time2 (2.3)2 (2.4)0
Required supplemental oxygen at any time27 (31.4)26 (31.7)1 (25.0)
Intensive care unit at any time17 (19.8)16 (19.5)1 (25.0)
Outcomes
In-hospital death25 (29.1)24 (29.3)1 (25.0)
Length of stay, median (range), d4.5 (1–8)4.5 (1–8)5.5 (2.5–8)
Deaths by qSOFA and UVA scoresb
 qSOFA <29 (17.0) of 539 (17.0) of 530 of 0
 qSOFA ≥216 (48.5) of 3315 (51.7) of 291 (25.0) of 4
 UVA <24 (10.5) of 384 (10.8) of 370 (0) of 1
 UVA 2–49 (30.0) of 309 (31.0) of 290 (0) of 1
 UVA ≥512 (66.7) of 1811 (68.8) of 161 (50.0) of 2

Data are presented as No. (%) unless otherwise noted.

Abbreviations: IQR, interquartile range; IV, intravenous; qSOFA, quick Sequential Organ Failure Assessment; UVA, Universal Vital Assessment.

aIncludes rapid HIV test, malaria rapid diagnostic test, urinalysis, urine culture, lumbar puncture, sputum culture, or any sputum acid-fast bacilli test, or any method of imaging.

bGiven as [# deaths] (%) of [# of cohort or subgroup in score category].

Table 2.

Management Characteristics and Outcomes of Adolescents and Adults With Sepsis, Northern Tanzania, September 2019–April 2020

 Total Cohort (n = 86)Sepsis Without Hypotension (n = 82)Sepsis With Hypotension (n = 4)
Management characteristics, h 0–6
Received antimicrobials by 2 h14 (16.3)14 (17.1)0
Received antimicrobials by 6 h29 (33.7)29 (35.4)0
 If received, time to antimicrobials by h 6, median (IQR), min129 (97–203)129 (97–203)n/a
Received any IV fluids by 3 h42 (51.2)38 (46.3)4 (100)
Received any IV fluids by 6 h49 (57.0)45 (54.9)4 (100)
 <1L IV fluids23 (46.9)20 (44.4)3 (75.0)
 1–2L IV fluids21 (42.9)20 (44.4)1 (25.0)
 >2L IV fluids5 (10.2)5 (11.1)0
 If received, total IV fluids by h 6, median (IQR), mL1000 (500–1500)1000 (500–1500)500 (350–750)
Blood cultures performed26 (30.2)25 (30.5)1 (25.0)
 If performed, obtained before antimicrobials given24 (92.3)23 (92.0)1 (100)
Other investigation for infectious source performeda65 (75.6)63 (76.8)2 (50.0)
Steroid administration3 (3.5)3 (3.7)0
Supplemental oxygen given17 (19.8)17 (20.7)0
Required emergent surgery1 (1.2)1 (1.2)0
Hospital course
Received ≥1 antimicrobial after admission48 (55.8)45 (54.9)3 (75.0)
Required vasopressors at any time2 (2.3)2 (2.4)0
Required supplemental oxygen at any time27 (31.4)26 (31.7)1 (25.0)
Intensive care unit at any time17 (19.8)16 (19.5)1 (25.0)
Outcomes
In-hospital death25 (29.1)24 (29.3)1 (25.0)
Length of stay, median (range), d4.5 (1–8)4.5 (1–8)5.5 (2.5–8)
Deaths by qSOFA and UVA scoresb
 qSOFA <29 (17.0) of 539 (17.0) of 530 of 0
 qSOFA ≥216 (48.5) of 3315 (51.7) of 291 (25.0) of 4
 UVA <24 (10.5) of 384 (10.8) of 370 (0) of 1
 UVA 2–49 (30.0) of 309 (31.0) of 290 (0) of 1
 UVA ≥512 (66.7) of 1811 (68.8) of 161 (50.0) of 2
 Total Cohort (n = 86)Sepsis Without Hypotension (n = 82)Sepsis With Hypotension (n = 4)
Management characteristics, h 0–6
Received antimicrobials by 2 h14 (16.3)14 (17.1)0
Received antimicrobials by 6 h29 (33.7)29 (35.4)0
 If received, time to antimicrobials by h 6, median (IQR), min129 (97–203)129 (97–203)n/a
Received any IV fluids by 3 h42 (51.2)38 (46.3)4 (100)
Received any IV fluids by 6 h49 (57.0)45 (54.9)4 (100)
 <1L IV fluids23 (46.9)20 (44.4)3 (75.0)
 1–2L IV fluids21 (42.9)20 (44.4)1 (25.0)
 >2L IV fluids5 (10.2)5 (11.1)0
 If received, total IV fluids by h 6, median (IQR), mL1000 (500–1500)1000 (500–1500)500 (350–750)
Blood cultures performed26 (30.2)25 (30.5)1 (25.0)
 If performed, obtained before antimicrobials given24 (92.3)23 (92.0)1 (100)
Other investigation for infectious source performeda65 (75.6)63 (76.8)2 (50.0)
Steroid administration3 (3.5)3 (3.7)0
Supplemental oxygen given17 (19.8)17 (20.7)0
Required emergent surgery1 (1.2)1 (1.2)0
Hospital course
Received ≥1 antimicrobial after admission48 (55.8)45 (54.9)3 (75.0)
Required vasopressors at any time2 (2.3)2 (2.4)0
Required supplemental oxygen at any time27 (31.4)26 (31.7)1 (25.0)
Intensive care unit at any time17 (19.8)16 (19.5)1 (25.0)
Outcomes
In-hospital death25 (29.1)24 (29.3)1 (25.0)
Length of stay, median (range), d4.5 (1–8)4.5 (1–8)5.5 (2.5–8)
Deaths by qSOFA and UVA scoresb
 qSOFA <29 (17.0) of 539 (17.0) of 530 of 0
 qSOFA ≥216 (48.5) of 3315 (51.7) of 291 (25.0) of 4
 UVA <24 (10.5) of 384 (10.8) of 370 (0) of 1
 UVA 2–49 (30.0) of 309 (31.0) of 290 (0) of 1
 UVA ≥512 (66.7) of 1811 (68.8) of 161 (50.0) of 2

Data are presented as No. (%) unless otherwise noted.

Abbreviations: IQR, interquartile range; IV, intravenous; qSOFA, quick Sequential Organ Failure Assessment; UVA, Universal Vital Assessment.

aIncludes rapid HIV test, malaria rapid diagnostic test, urinalysis, urine culture, lumbar puncture, sputum culture, or any sputum acid-fast bacilli test, or any method of imaging.

bGiven as [# deaths] (%) of [# of cohort or subgroup in score category].

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close